Interim report 2017

Read about Swelife’s completed, ongoing and new activities and projects, contributing to innovations in healthcare and to making Swedish Life Science attractive and internationally competitive.  

Precision diagnostics: crucial to meet the new needs

The right measurement ensures the right treatment, which is why precision diagnostics is the right way to go, says Professor Carl Borrebaeck, one of the speakers at the upcoming Nordic Precision Medicine Forum in Copenhagen. Precision diagnostics is a research…

SWElife’s Sarah Fredriksson top-candidate for EU prize

Sarah Fredriksson, founder of Swedish life science company Genovis and one of SWElife’s project development co-ordinators, is one of the top candidates for the EU prize for women innovators 2016. The winners will be announced in early March. Sarah Fredriksson…

Recently funded projects

Seven projects have received funding from SWElife through VINNOVA. Applications were made to the SWElife 2015 open call for “Predictive or prognostic biomarkers in tumour diseases”. Recently funded projects Additive Multiple Labeling Cytochemistry (AMLC) – en ny metod för förbättrad in vitro diagnostik…

Recently funded projects

Ten projects have received funding from SWElife through VINNOVA. Applications were made to the SWElife spring 2015 call, for proposals for collaborative innovation projects within non-communicable diseases. Recently funded projects New cell-on-chip technology improves allergy diagnostics. Project leader, Anna Nopp Scherman; Main…

Q&A about SWElife “We need to go from words to action”

SWElife will build on already existing competence and infrastructure and will rather focus on enhancing cooperation between stakeholders and changing the mind set and collaborative culture in Sweden, says Peter Nordström, Programme Director for SWElife. What is SWElife? The programme…

For a competitive life science ecosystem in Sweden

With support from: